Judge finds AbbVie pursued objectively baseless litigation
A federal judge has agreed with the Federal Trade Commission that AbbVie and Besins Healthcare pursued "objectively baseless" litigation when they sued rival drugmakers in an apparent attempt to delay the Federal Drug Administration's approval of generic versions to AndroGel.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10